Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 75.

Man, Stella, Foster, Julie, Carapuca, Elisabete, Davies, James A, Parker, Alan, Sosabowski, Jane and Hallden, Gunnel 2019. Systemic delivery and SPECT/CT in vivo imaging of 125I-labelled oncolytic adenoviral mutants in models of pancreatic cancer. Scientific Reports 9 , 12840. 10.1038/s41598-019-49150-9
file

Baker, Alexander, Mundy, Rosie M., Davies, James A., Rizkallah, Pierre and Parker, Alan L. 2019. Human adenovirus type 26 uses sialic acid - bearing glycans as a primary cell entry receptor. Science Advances 5 (9) , eaax3567. 10.1126/sciadv.aax3567
file

Baker, Alexander T., Mundy, Rosie, Davies, James, Rizkillah, Pierre T. and Parker, Alan L. 2019. Adenovirus serotype 26 utilises sialic acid bearing glycans as a primary cell entry receptor. bioRxiv 10.1101/580076
file

Baker, Alexander T., Greenshields-Watson, Alexander, Coughlan, Lynda, Davies, James A., Uusi-Kerttula, Hanni, Cole, David K., Rizkallah, Pierre J. and Parker, Alan L. 2019. Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactions. Nature Communications 10 (1) , -. 10.1038/s41467-019-08599-y
file

Uusi-Kerttula, Hanni, Davies, James A, Thompson, Jill, Wongthida, Phonphimon, Evgin, Laura, Shim, Kevin G., Bradshaw, Angela, Baker, Alexander T, Rizkallah, Pierre J, Jones, Rachel, Hanna, Louise, Hudson, Emma, Vile, Richard, Chester, John D and Parker, Alan L 2018. Ad5NULL-A20 - a tropism-modified, αvβ6 integrin-selective oncolytic adenovirus for epithelial ovarian cancer therapies. Clinical Cancer Research 24 (17) , pp. 4215-4224. 10.1158/1078-0432.CCR-18-1089
file

Baker, Alexander, Aguirre-Hernández, Carmen, Halldén, Gunnel and Parker, Alan 2018. Designer oncolytic adenovirus: coming of age. Cancers 10 (6) , 201. 10.3390/cancers10060201
file

Hulin-Curtis, Sarah, Davies, James A., Jones, Rachel, Hudson, Emma, Hanna, Louise, Chester, John D. and Parker, Alan L. 2018. Histone deacetylase inhibitor trichostatin A sensitises cisplatin-resistant ovarian cancer cells to oncolytic adenovirus. Oncotarget 9 (41) , pp. 26328-26341. 10.18632/oncotarget.25242
file

Man, Y. K. Stella, Davies, James A., Coughlan, Lynda, Pantelidou, Constantia, Blázquez-Moreno, Alfonso, Marshall, John F., Parker, Alan L. and Halldén, Gunnel 2018. The novel oncolytic adenoviral mutant Ad5-3Δ-A20T retargeted to αvβ6 integrins efficiently eliminates pancreatic cancer cells. Molecular Cancer Therapeutics 17 (2) , pp. 575-587. 10.1158/1535-7163.MCT-17-0671
file

Uusi-Kerttula, Hanni and Parker, Alan L. 2018. Precision virotherapies: Coming soon. Oncotarget 9 (86) 10.18632/oncotarget.26280
file

Yan, Bing, Wang, Zengbo, Parker, Alan, Lai, Yukun, Thomas, John P., Yue, Liyang and Monks, James N. 2017. Superlensing microscope objective lens. Applied Optics 56 (11) , pp. 3142-3147. 10.1364/AO.56.003142
file

Robertson, Stacy, Alba, Raul, Duffy, Margeret R., Clarke, Carolyn, Parker, Alan L., Nicklin, Stuart A. and Baker, Andrew H. 2016. Retargeting FX binding-ablated HAdV-5 to vascular cells by inclusion of the RGD-4C peptide in hexon hypervariable region 7 and the HI loop. Journal of General Virology 97 (8) , pp. 1911-1916. 10.1099/jgv.0.000505
file

Hulin-Curtis, Sarah, Uusi-Kerttula, Hanni, Jones, R., Hanna, L., Chester, John D. and Parker, Alan L. 2016. Evaluation of CD46 re-targeted adenoviral vectors for clinical ovarian cancer intraperitoneal therapy. Cancer Gene Therapy 23 (7) , pp. 229-234. 10.1038/cgt.2016.22
file

Uusi-Kerttula, Hanni, Davies, James, Curtis, Sarah, Chester, John and Parker, Alan 2016. Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies. Oncotarget 7 (19) , pp. 27926-27937. 10.18632/oncotarget.8545
file

Uusi-Kerttula, Hanni, Hulin-Curtis, Sarah, Davies, James Anthony and Parker, Alan L. 2015. Oncolytic adenovirus: strategies and insights for vector design and immuno-oncolytic applications. Viruses 7 (11) , pp. 6009-6042. 10.3390/v7112923
file

Uusi-Kerttula, Hanni, Davies, J. A., Coughlan, L., Chester, J. D., Parker, Alan L. and Parker, A. L. 2015. Incorporation of avß6 integrin-targeting peptide into chimaeric Ad5/fibre knob 48 vector results in efficient tumour-targeting and evasion of neutralisation in clinical ascites. Human Gene Therapy 26 (10) , A93-A93. 10.1089/hum.2015.29008.abstracts

Hulin-Curtis, Sarah, Uusi-Kerttula, Hanni, Jones, Rachel, Baker, Andrew, Chester, John D. and Parker, Alan L. 2015. Evaluation of CD46 utilising adenoviral vectors for clinical ovarian cancer applications [Abstract]. Human Gene Therapy 26 (9) , A33-A34. 10.1089/hum.2015.29005.abstracts

Uusi-Kerttula, Hanni, Davies, James, Coughlan, Lynda, Jones, Rachel, Chester, John D. and Parker, Alan L. 2015. Development of an Ad5 vector pseudotyped with Ad48 knob protein and targeted to αvβ6 integrin efficiently targets tumour cells and evades pre-existing immunity in clinical ascites. Human Gene Therapy 26 (9) , A33-A33. 10.1089/hum.2015.29005.abstracts

Uusi-Kerttula, Hanni, Legut, Mateusz, Davies, James, Jones, Rachel, Hudson, Emma, Hanna, Louise, Stanton, Richard J., Chester, John D. and Parker, Alan L. 2015. Modulation of Ad5 fibre knob as a means of circumventing pre-existing immunity in clinical ovarian ascites. Human Gene Therapy 26 (9) , A23-A23. 10.1089/hum.2015.29005.abstracts

Uusi-Kerttula, Hanni, Legut, Mateusz, Davies, James Anthony, Jones, Rachel, Hudson, Emma, Hanna, Louise, Stanton, Richard James, Chester, John D. and Parker, Alan L. 2015. Incorporation of peptides targeting EGFR and FGFR1 into the adenoviral fibre knob domain, and their evaluation as targeted cancer therapies. Human Gene Therapy 26 (5) , pp. 320-329. 10.1089/hum.2015.015
file

Dakin, Rachel S., Parker, Alan L., Delles, Christian, Nicklin, Stuart A. and Baker, Andrew H. 2015. Efficient transduction of primary vascular cells by the rare adenovirus serotype 49 vector. Human Gene Therapy 26 (5) , pp. 312-319. 10.1089/hum.2015.019
file

Nivsarkar, Megha S., Buckley, Suzanne M. K., Parker, Alan L., Perocheau, Dany, McKay, Tristan R., Rahim, Ahad A., Howe, Steven J. and Waddington, Simon N. 2015. Evidence for contribution of CD4+CD25+ regulatory T cells in maintaining immune tolerance to human factor IX following perinatal adenovirus vector delivery. Journal of Immunology Research 2015 , 397879. 10.1155/2015/397879
file

Guinn, Barbara-ann, Braidwood, Lynne, Parker, Alan, Peng, Kah-Whye and Seymour, Leonard 2014. 8th international conference on oncolytic virus therapeutics. Human Gene Therapy 25 (12) , pp. 1062-1084. 10.1089/hum.2014.118

Dakin, R. S., Parker, Alan, Ma, J., Custers, J., Nicklin, S. A. and Baker, A. H. 2014. Efficient gene transfer to human vascular cells in vitro and ex vivo using adenovirus serotype 49. Cardiovascular Research 103 (suppl) , S42. 10.1093/cvr/cvu082.170

Coughlan, Lynda, Uusi-Kerttula, Hanni, Ma, Jiangtao, Degg, Bethany P., Parker, Alan L. and Baker, Andrew H. 2014. Retargeting adenovirus serotype 48 fiber knob domain by peptide incorporation. Human Gene Therapy 25 (4) , pp. 385-394. 10.1089/hum.2014.016

Parker, Alan L., Bradshaw, Angela C., Alba, Raul, Nicklin, Stuart A. and Baker, Andrew H. 2013. Capsid modification strategies for detargeting adenoviral vectors. In: Chillon, Miguel and Bosch, Assumpcio eds. Adenovirus, Vol. 1089. Methods in Molecular Biology, Humana Press, pp. 45-59. (10.1007/978-1-62703-679-5_3)

Parker, Alan L., White, K M, Lavery, C A, Custers, J, Waddington, S N and Baker, A H 2013. Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction. Gene Therapy 20 (12) , pp. 1158-1164. 10.1038/gt.2013.44

White, Katie M, Alba, Raul, Parker, Alan L., Wright, Audrey F, Bradshaw, Angela C, Delles, Christian, McDonald, Robert A and Baker, Andrew H 2013. Assessment of a novel, capsid-modified adenovirus with an improved vascular gene transfer profile. Journal of Cardiothoracic Surgery 8 (1) , 183. 10.1186/1749-8090-8-183

Kaur, H., Toukh, M., Corscadden, K., Parker, Alan L. and Othman, M. 2013. Fucoidan improves adenovirus mediated thrombocytopenia and enhances viral liver transduction [Abstract]. Journal of Thrombosis and Haemostatis 11 (S1) , pp. 451-452. 10.1111/jth.12284

Duffy, Margaret R., Parker, Alan L., Kalkman, Eric R., White, Katie, Kovalskyy, Dmytro, Kelly, Sharon M. and Baker, Andrew H. 2013. Identification of novel small molecule inhibitors of adenovirus gene transfer using a high throughput screening approach. Journal of Controlled Release 170 (1) , pp. 132-140. 10.1016/j.jconrel.2013.05.007

Coughlan, Lynda, Bradshaw, Angela C., Parker, Alan L., Robinson, Hollie, White, Katie, Custers, Jerome, Goudsmit, Jaap, Van Roijen, Nico, Barouch, Dan H., Nicklin, Stuart A. and Baker, Andrew H. 2012. Ad5:Ad48 hexon hypervariable region substitutions lead to toxicity and increased inflammatory responses following intravenous delivery. Molecular Therapy 20 (12) , pp. 2268-2281. 10.1038/mt.2012.162

Duffy, Margaret R., Parker, Alan L., Bradshaw, Angela C. and Baker, Andrew H. 2012. Manipulation of adenovirus interactions with host factors for gene therapy applications. Nanomedicine 7 (2) , pp. 271-288. 10.2217/nnm.11.186

Duffy, M. R., Bradshaw, A. C., Parker, Alan L., McVey, J. H. and Baker, A. H. 2011. A cluster of basic amino acids in the factor X serine protease mediate surface attachment of adenovirus:FX complexes [Abstract]. Human Gene Therapy 22 (10) , A34-A34. 10.1089/hum.2011.2525

Coughlan, Lynda, Uusi-Kerttula, Hanni, Degg, B., Parker, Alan L., Custers, Jerome, Nicklin, Stuart A. and Baker, Andrew H. 2011. In vitro assessment of targeting peptide incorporation within the knob domain of human adenovirus type 48 fiber. Human Gene Therapy 22 (10) , A128-A128.

Duffy, Margaret R., Bradshaw, Angela C., Parker, Alan L., McVey, John H. and Baker, Andrew H. 2011. A Cluster of Basic Amino Acids in the Factor X Serine Protease Mediates Surface Attachment of Adenovirus/FX Complexes. Journal of Virology 85 (20) , pp. 10914-10919. 10.1128/JVI.05382-11
file

Kitahara, Hiroe, Masumoto, Junya, Parker, Alan L., Maruta, Fukuto, Kubo, Naoki, Shimizu, Akira, Akita, Noriyuko, Miwa, Shiro, Kobayashi, Naoya, Nakayama, Jun and Miyagawa, Shinichi 2011. COP35, a cholangiocarcinoma-binding oligopeptide, interacts with the clathrin heavy chain accompanied by GRP78. Molecular Cancer Research 9 (6) , pp. 688-701. 10.1158/1541-7786.MCR-10-0470

Othman, Maha, Chirinian, Yvette, Brown, Christine, Notley, Colleen, Hickson, Nicholas, Hampshire, Daniel, Buckley, Suzanne, Waddington, Simon, Parker, Alan L., Baker, Andrew, James, Paula and Lillicrap, David 2010. Functional characterization of a 13-bp deletion (c.-1522_-1510del13) in the promoter of the von Willebrand factor gene in type 1 von Willebrand disease. Blood 116 (18) , pp. 3645-3652. 10.1182/blood-2009-12-261131

Alba, Raul, Bradshaw, Angela C., Coughlan, Lynda, Denby, Laura, McDonald, Robert A., Waddington, Simon N., Buckley, Suzanne M. K., Greig, Jenny A., Parker, Alan L., Miller, Ashley M., Wang, Hongjie, Lieber, Andre, van Rooijen, Nico, McVey, John H,, Nicklin, Stuart A. and Baker, Andrew H. 2010. Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors. Blood 116 (15) , pp. 2656-2664. 10.1182/blood-2009-12-260026

Bradshaw, Angela C., Parker, Alan L., Duffy, Margaret R., Coughlan, Lynda, van Rooijen, Nico, Kahari, Veli-Matti, Nicklin, Stuart A. and Baker, Andrew H. 2010. Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X. Plos Pathogens 6 (10) , e1001142. 10.1371/journal.ppat.1001142
file

Coughlan, Lynda, Alba, Raul, Parker, Alan L., Bradshaw, Angela C., McNeish, Iain A., Nicklin, Stuart A. and Baker, Andrew H. 2010. Tropism-modification strategies for targeted gene delivery using adenoviral vectors. Viruses 2 (10) , pp. 2290-2355. 10.3390/v2102290
file

Duffy, Margaret R., Bradshaw, Angela C., Parker, Alan L., Nicklin, Stuart A., McVey, John H. and Baker, Andrew H. 2010. Modification of the factor X serine protease domain ablates heparan sulfate proteoglycan engagement by Ad5-FX complexes. Human Gene Therapy 21 (9) , p. 1187. 10.1089/hum.2010.804

Collins, Louise, Parker, Alan L., Gehman, John D., Eckley, Lorna, Perugini, Matthew A., Separovic, Frances and Fabre, John W. 2010. Self-assembly of peptides into spherical nanoparticles for delivery of hydrophilic moieties to the cytosol. ACS Nano 4 (5) , pp. 2856-2864. 10.1021/nn901414q

Parker, Alan L., Alba, Raul, Barouch, D. H., Delles, C. and Baker, Andrew H. 2010. In vitro evaluation of hexon modifications on the capacity of Ad5 to evade neutralising antibodies. Human Gene Therapy 21 (4) , p. 518. 10.1089/hum.2010.1225

Duffy, Margaret R., Bradshaw, Angela C., Parker, Alan L., Nicklin, Stuart A., McVey, John H. and Baker, Andrew H. 2010. Modification of the FX serine protease domain ablates HSGP engagment by Ad5/FX complexes. Human Gene Therapy 21 (4) , pp. 512-513. 10.1089/hum.2010.1225

Alba, Raul, Bradshaw, Angela C., McDonald, Robert A., Coughlan, Lynda, Parker, Alan, Miller, Ashley M., van Rooijen, Nico, Nicklin, Stuart A. and Baker, Andrew H. 2010. Biodistribution and inflammatory profiles of hepatocyte-detargeted FX-binding ablated Ad5 vectors. Human Gene Therapy 21 (4) , pp. 498-499. 10.1089/hum.2010.1224

Greig, Jenny A., Buckley, Suzanne M. K., Waddington, Simon N., Parker, Alan L., Bhella, David, Pink, Rebecca, Rahim, Ahad A., Morita, Takashi, Nicklin, Stuart A., Mcvey, John H. and Baker, Andrew H. 2009. Influence of coagulation factor X on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors. Molecular Therapy 17 (10) , pp. 1683-1691. 10.1038/mt.2009.152

Alba, Raul, Bradshaw, Angela C., Parker, Alan L., Bhella, David, Waddington, Simon N., Nicklin, Stuart A., van Rooijen, Nico, Custers, Jerome, Goudsmit, Jaap, Barouch, Dan, Mcvey, John H. and Baker, Andrew H. 2009. Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood 114 (5) , pp. 965-971. 10.1182/blood-2009-03-208835

Greig, Jenny A., Buckley, Suzanne M. K., Waddington, Simon N., Parker, Alan L., Bhella, D., Pink, R., Morita, T., Custers, Jerome, Goudsmit, J., Nicklin, Stuart A., Mcvey, John H. and Baker, Andrew H. 2009. Influence of factor X on in vitro and in vivo gene delivery by Ad5 and Ad35 vectors. Molecular Therapy 17 , S325-S325.

Parker, Alan L., Waddington, Simon N., Miller, A. M., Buckley, Suzanne M., Nicklin, Stuart A., McClure, J. D., McBride, M. W., Lee, W., McVey, John H. and Baker, Andrew H. 2009. Genome wide and micro RNA profiling of murine livers following acute phase intravenous delivery of Ad5 reveals subsets of hepatocyte and kupffer cell regulated genes. Molecular Therapy 17 , S43-S44.

Alba, R., Bradshaw, Angela C., Parker, Alan L., Bhella, D., Nicklin, Stuart A., Waddington, Simon N., Custers, Jerome, Goudsmit, J., Van Rooijen, Nico, Barouch, D. H., MacVey, John H. and Baker, Andrew H. 2009. Selected modification of the adenovirus type 5 hexon modulates interaction with coagulation factor X and hepatocyte transduction in vivo. Molecular Therapy 17 , S6-S6.

Parker, Alan, Waddington, Simon N., Buckley, Suzanne M. K., Custers, Jerome, Havenga, M. J. E., van Rooijen, Nico., Goudsmit, J., Mcvey, John H., Nicklin, Stuart A. and Baker, Andrew H. 2009. Effect of neutralizing sera on factor x-mediated adenovirus serotype 5 gene transfer. Journal of Virology 83 (1) , pp. 479-483. 10.1128/JVI.01878-08
file

Parker, Alan, Nicklin, Stuart A. and Baker, Andrew H. 2008. Interactions of adenovirus vectors with blood: Implications for intravascular gene therapy applications. Current Opinion in Molecular Therapeutics 10 (5) , pp. 439-448.

Waddington, Simon N., Mcvey, John H., Bhella, D., Parker, Alan L., Barker, K., Atoda, K., Pink, R., Buckley, Suzanne M. K., Greig, Jenny A., Denby, Laura, Custers, Jerome, Morita, T., Francischetti, I. M. B., Monteiro, R. Q., Barouch, D. H., van Rooijen, Nico, Napoli, C., Havenga, M., Nicklin, Stuart A, and Baker, Andrew H. 2008. A critical role for the adenovirus serotype 5 hexon in liver gene transfer. Human Gene Therapy 19 (4) , p. 409. 10.1089/hum.2008.1327

Parker, Alan, McVey, John H., Waddington, Simon N., Buckley, Suzanne M. K., Francischetti, I. M. B., Monteiro, R. Q., Nicklin, Stuart A. and Baker, Andrew H. 2008. An exosite within the human FX serine protease domain mediates cell transduction of AD5: FX complexes. Human Gene Therapy 19 (4) , p. 407. 10.1089/hum.2008.1327

Greig, Jenny A., Mcvey, John H., Waddington, Simon N., Parker, Alan L., Buckley, Suzanne M. K., Havenga, M. J. E., Nicklin, Stuart A. and Baker, Andrew H. 2008. Factor X enhances binding and transduction of human cancer cell lines by adenovirus (Ad) serotype 5 vectors but not by Ad35. Human Gene Therapy 19 (4) , p. 398.

Waddington, Simon N., Mcvey, John H., Bhella, David, Parker, Alan L., Barker, Kristeen, Atoda, Hideko, Pink, Rebecca, Buckley, Suzanne M. K., Greig, Jenny A., Denby, Laura, Custers, Jerome, Morita, Takashi, Francischetti, Ivo M. B., Monteiro, Robson Q., Barouch, Dan H., van Rooijen, Nico, Napoli, Claudio, Havenga, Menzo J. L., Nicklin, Stuart A. and Baker, Andrew H. 2008. Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132 (3) , pp. 397-409. 10.1016/j.cell.2008.01.016

Kubo, Naoki, Akita, Noriyuki, Shimizu, Akira, Kitahara, Hiroe, Parker, Alan L. and Miyagawa, Shinichi 2008. Identification of oligopeptide binding to colon cancer cells separated from patients using laser capture microdissection. Journal of Drug Targeting 16 (5) , pp. 396-404. 10.1080/10611860802088796

Waddington, Simon N., Parker, Alan L., Havenga, Menzo, Nicklin, Stuart A., Buckley, Suzanne M. K., McVey, John H. and Baker, Andrew H. 2007. Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: Fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5. Journal of Virology 81 (17) , pp. 9568-9571. 10.1128/JVI.00663-07
file

Parker, Alan L., Eckley, Lorna, Singh, Surjeet, Preece, Jon A., Collins, Louise and Fabre, John W. 2007. (LYS)(16)-based reducible polycations provide stable polyplexes with anionic fusogenic peptides and efficient gene delivery to post mitotic cells. Biochimica et Biophysica Acta (BBA) - General Subjects 1770 (9) , pp. 1331-1337. 10.1016/j.bbagen.2007.06.009

Parker, Alan L., McVey, John H., Doctor, Jessica H., Lopez-Franco, Oscar, Waddington, Simon N., Havenga, Menzo J. E., Nicklin, Stuart A. and Baker, Andrew H. 2007. Influence of coagulation factor zymogens on the infectivity of adenoviruses pseudotyped with fibers from subgroup D. Journal of Virology 81 (7) , pp. 3627-3631. 10.1128/JVI.02786-06
file

Maruta, Fukuto, Akita, Noriyuki, Nakayama, Jun, Miyagawa, Sinichi, Ismail, Tariq, Rowlands, David C., Kerr, David J., Fisher, Kerry D., Seymour, Leonard W. and Parker, Alan L. 2007. Bacteriophage biopanning in human tumour biopsies to identify cancer-specific targeting ligands. Journal of Drug Targeting 15 (4) , pp. 311-319. 10.1080/10611860701195510

Akita, Noriyuki, Maruta, Fukuto, Seymour, Leonard W., Kerr, David J., Parker, Alan L., Asai, Tomohiro, Oku, Naoto, Nakayama, Jun and Miyagawa, Shinichi 2006. Identification of oligopeptides binding to peritoneal tumors of gastric cancer. Cancer Science 97 (10) , pp. 1075-1081. 10.1111/j.1349-7006.2006.00291.x

Parker, Alan L., Waddington, Simon N., Nicol, Campbell G., Shayakhmetov, Dmitry M., Buckley, Suzanne M., Denby, Laura, Kemball-Cook, Geoffrey, Ni, Shaoheng, Lieber, Andre, McVey, John H., Nicklin, Stuart A. and Baker, Andrew H. 2006. Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood 108 (8) , pp. 2554-2561. 10.1182/blood-2006-04-008532

Parker, Alan L., Nicol, Campbell G., Waddington, Simon N., Buckley, Suzanne M., Shayakhmetov, Dmitry M., Ni, Shaoheng H., Lieber, Andre, McVey, John H., Denby, Laura, Nicklin, Stuart A. and Baker, Andrew H. 2006. Hepatic tropism of adenoviral type 5 vectors can be mediated by multiple coagulation factors. Molecular Therapy 13 (S1) , S143-S143. 10.1016/j.ymthe.2006.08.436

Shimizu, A., Maruta, F., Akita, N., Miwa, S., Seymour, L. W., Kerr, D. J., Parker, Alan L. and Miyagawa, S. 2006. Identification of an oligopeptide binding to hepatocellular carcinoma. Oncology 71 (1-2) , pp. 136-145. 10.1159/000100479

Parker, Alan L., Collins, Louise, Zhang, X. H. and Fabre, John W. 2005. Exploration of peptide motifs for potent non-viral gene delivery highly selective for dividing cells. Journal of Gene Medicine 7 (12) , pp. 1545-1554. 10.1002/jgm.809

Read, Martin L., Spice, Rachel, Parker, Alan L., Mir, Sohaib and Logan, Ann 2005. 12th Annual Congress of the European Society of Gene Therapy. Expert Opinion on Biological Therapy 5 (1) , pp. 137-141. 10.1517/14712598.5.1.137

Parker, Alan L., Fisher, Kerry D., Oupicky, David, Read, Martin L., Nicklin, Stuart A., Baker, Andrew H. and Seymour, Leonard W. 2005. Enhanced gene transfer activity of peptide-targeted gene-delivery vectors. Journal of Drug Targeting 13 (1) , pp. 39-51. 10.1080/10611860400020449

Parker, Alan L., Collins, Louise, Zhang, X. H. and Fabre, John W. 2004. Free and (Lys)(16) containing fusogenic peptides for non-viral gene delivery to dividing and post mitotic cells. Journal of Gene Medicine 6 (9) , S13-S13.

Parker, Alan L., Newman, Christopher, Briggs, Simon, Seymour, Leonard and Sheridan, Paul J. 2004. Nonviral gene delivery: techniques and implications for molecular medicine. Expert Reviews in Molecular Medicine 5 , pp. 1-15. 10.1017/S1462399403006562

Maruta, Fukuto, Parker, Alan L., Fisher, Kerry D., Murray, Paul G., Kerr, David J. and Seymour, Leonard W. 2003. Use of a phage display library to identify oligopeptides binding to the lumenal surface of polarized endothelium by ex vivo perfusion of human umbilical veins. Journal of Drug Targeting 11 (1) , pp. 53-59.

Parker, Alan L. and Seymour, Leonard W. 2002. Targeting of polyelectrolyte RNA complexes to cell surface integrins as an efficient cytoplasmic transfection mechanism. Journal of Bioactive and Compatible Polymers 17 (4) , pp. 229-238. 10.1106/088391102027977

Maruta, Fukuto, Parker, Alan L., Fisher, Kerry D., Hallissey, Michael T., Ismail, Tariq, Rowlands, David C., Chandler, Lois A., Kerr, David J. and Seymour, Leonard W. 2002. Identification of FGF receptor-binding peptides for cancer gene therapy. Cancer Gene Therapy 9 (6) , pp. 543-552. 10.1038/sj.cgt.7700470

Parker, Alan L., Oupicky, David, Dash, Philip R. and Seymour, Leonard W. 2002. Methodologies for monitoring, nanoparticle formation by self-assembly of DNA with poly(L-lysine). Analytical Biochemistry 302 (1) , pp. 75-80. 10.1006/abio.2001.5507

Oupicky, David, Parker, Alan L. and Seymour, Leonard W. 2002. Laterally stabilized complexes of DNA with linear reducible polycations: Strategy for triggered intracellular activation of DNA delivery vectors. Journal of the American Chemical Society 124 (1) , pp. 8-9. 10.1021/ja016440n

Carlisle, R. C., Fisher, K. D., Parker, Alan L. and Seymour, Leonard W. 2000. Systems for gene delivery based on combination of viral and non-viral vectors. Targeting of Drugs 323 , pp. 117-125.

This list was generated on Wed Oct 16 05:11:27 2019 BST.